Significant role of cell scaffolding and DDS technology in tissue regeneration: Tissue engineering strategies

International Congress Series

Volumn 1284, Issue , 2005, Pages 257-265

  Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cell scaffolding; Drug delivery system; Growth factor tissue regeneration; Tissue engineering

Indexed keywords

EID: 33646448301     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2005.06.051     Document Type: Article

References (24)

1. Tabata Y. Significant role of tissue engineering in regenerative medicine. J. Hard Tissue Biol. 12 (2003) 33-43
2. Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng. 9 (2003) S5-S15
3. Kushibiki T., and Tabata Y. A new gene delivery system based on controlled release technology. Curr. Drug Deliv. 1 (2004) 153-163
4. Yamamoto M., et al. Improved therapeutic efficacy in cardiomyocyte transplantation for myocardial infarction with release system of basic fibroblast growth factor. Artif. Organs 27 (2003) 181-184
5. Nakajima H., et al. Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury: toward safety and minimal invasiveness. J. Artif. Organs 7 (2004) 58-61
6. Sakakibara Y., et al. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J. Thorac. Cardiovasc. Surg. 124 (2002) 50-56
7. Balamurugan A.N., et al. Effect of hepatocyte growth factor (HGF) is a mitogen and an insulinotropic agent for fetal islet cells in vitro. Pancreas 26 (2003) 103-104
8. Ogawa K., et al. The efficacy of prevascularization by basic FGF for hepatocyte transplantation using polymer devices in rats. Cell transplant 10 (2001) 723-729
9. Saito A., et al. Bioengineered implantation of megalin-expressing cells: a potential intracorporeal therapeutic model for uremic toxin protein clearance in renal failure. J. Am. Soc. Nephrol. 14 (2003) 2025-2032
10. Tabata Y., et al. Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogel. Biomaterials 19 (1998) 807-815
11. Tabata Y., et al. Skull bone regeneration in primates in response to basic fibroblast growth factor. J. Neurosurg. 91 (1999) 851-856
12. Nakano T., et al. Peculiar alignment and texture of apatite (Ap) crystallines in typical calcified tissues by micro-beam X-ray diffractometer. Bone 31 (2002) 479-487
13. Iwakura A., et al. Gelatin sheet incorporating basic fibroblast growth factor enhances healing of devascularized sternum in diabetic rats. Circulation 104 (2001) I325-I329
14. Hong L., et al. Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution. J. Biomater. Sci., Polym. Ed. 9 (1998) 1001-1014
15. Hong L., et al. Bone regeneration at rabbit skull defects treated with transforming growth factor-β1 incorporated into hydrogels with different levels of biodegradability. J. Neurosurg. 92 (2000) 315-325
16. Yamamoto M., et al. Bone regeneration by transforming growth factor-β1 released from a biodegradable hydrogel. J. Control. Release 64 (2000) 133-142
17. Hong L., et al. Promoted bone healing at rabbit skull gap between autologous bone fragment and the surrounding intact bone with biodegradabale microspheres containing transforming growth factor-β1. Tissue Eng. 6 (2000) 331-340
18. Yamamoto M., Takahashi Y., and Tabata Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24 (2003) 4375-4383
19. Hokugo A., et al. Bone regeneration activity of Platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng. 11 (2005) 1224-1233
20. Tabata Y., et al. Bone formation at a rabbit skull defect by autologous bone marrow cells combined with gelatin microspheres containing TGF-beta1. J. Biomater. Sci., Polym. Ed. 11 (2000) 891-901
21. Kojima K., et al. Tissue-engineered trachea from sheep marrow stromal cells with transforming growth factor β2 released from biodegradable microspheres in a nude rat recipient. Thorac. Cardiovasc. Surg. 128 (2004) 147-153
22. Kimura Y., et al. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 24 (2003) 2513-2521
23. Kasahara H., et al. Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia. J. Am. Coll. Cardiol. 41 (2003) 1056-1062
24. Nagaya N., et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 108 (2003) 889-895